Logo image of MNST

MONSTER BEVERAGE CORP (MNST) Stock Fundamental Analysis

NASDAQ:MNST - Nasdaq - US61174X1090 - Common Stock - Currency: USD

63.24  +0.25 (+0.4%)

Fundamental Rating

6

MNST gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 32 industry peers in the Beverages industry. Both the health and profitability get an excellent rating, making MNST a very profitable company, without any liquidiy or solvency issues. MNST is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, MNST could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

MNST had positive earnings in the past year.
MNST had a positive operating cash flow in the past year.
In the past 5 years MNST has always been profitable.
Each year in the past 5 years MNST had a positive operating cash flow.
MNST Yearly Net Income VS EBIT VS OCF VS FCFMNST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

MNST has a Return On Assets of 18.35%. This is amongst the best in the industry. MNST outperforms 96.88% of its industry peers.
MNST has a Return On Equity of 23.16%. This is in the better half of the industry: MNST outperforms 71.88% of its industry peers.
MNST has a Return On Invested Capital of 23.04%. This is amongst the best in the industry. MNST outperforms 96.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MNST is significantly above the industry average of 11.91%.
The last Return On Invested Capital (23.04%) for MNST is above the 3 year average (19.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.35%
ROE 23.16%
ROIC 23.04%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
MNST Yearly ROA, ROE, ROICMNST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

MNST has a Profit Margin of 20.27%. This is amongst the best in the industry. MNST outperforms 90.63% of its industry peers.
MNST's Profit Margin has declined in the last couple of years.
The Operating Margin of MNST (28.00%) is better than 87.50% of its industry peers.
In the last couple of years the Operating Margin of MNST has declined.
MNST has a better Gross Margin (54.64%) than 68.75% of its industry peers.
MNST's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 28%
PM (TTM) 20.27%
GM 54.64%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
MNST Yearly Profit, Operating, Gross MarginsMNST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

MNST has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for MNST has been reduced compared to 1 year ago.
Compared to 5 years ago, MNST has less shares outstanding
MNST has a worse debt/assets ratio than last year.
MNST Yearly Shares OutstandingMNST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MNST Yearly Total Debt VS Total AssetsMNST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

MNST has an Altman-Z score of 25.09. This indicates that MNST is financially healthy and has little risk of bankruptcy at the moment.
MNST has a Altman-Z score of 25.09. This is amongst the best in the industry. MNST outperforms 96.88% of its industry peers.
MNST has a debt to FCF ratio of 0.12. This is a very positive value and a sign of high solvency as it would only need 0.12 years to pay back of all of its debts.
The Debt to FCF ratio of MNST (0.12) is better than 87.50% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that MNST is not too dependend on debt financing.
MNST has a better Debt to Equity ratio (0.03) than 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.12
Altman-Z 25.09
ROIC/WACC2.53
WACC9.1%
MNST Yearly LT Debt VS Equity VS FCFMNST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 3.37 indicates that MNST has no problem at all paying its short term obligations.
The Current ratio of MNST (3.37) is better than 87.50% of its industry peers.
A Quick Ratio of 2.78 indicates that MNST has no problem at all paying its short term obligations.
MNST's Quick ratio of 2.78 is amongst the best of the industry. MNST outperforms 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 2.78
MNST Yearly Current Assets VS Current LiabilitesMNST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

MNST shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.75%.
The Earnings Per Share has been decreasing by -4.72% on average over the past years.
Looking at the last year, MNST shows a small growth in Revenue. The Revenue has grown by 1.47% in the last year.
MNST shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.27% yearly.
EPS 1Y (TTM)3.75%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%11.9%
Revenue 1Y (TTM)1.47%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%-2.35%

3.2 Future

The Earnings Per Share is expected to grow by 13.22% on average over the next years. This is quite good.
MNST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.08% yearly.
EPS Next Y18.16%
EPS Next 2Y14.53%
EPS Next 3Y12.98%
EPS Next 5Y13.22%
Revenue Next Year6.3%
Revenue Next 2Y7.13%
Revenue Next 3Y7.11%
Revenue Next 5Y8.08%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MNST Yearly Revenue VS EstimatesMNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
MNST Yearly EPS VS EstimatesMNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MNST is valuated quite expensively with a Price/Earnings ratio of 38.10.
Compared to the rest of the industry, the Price/Earnings ratio of MNST is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.60, MNST is valued a bit more expensive.
A Price/Forward Earnings ratio of 29.95 indicates a quite expensive valuation of MNST.
MNST's Price/Forward Earnings is on the same level as the industry average.
MNST is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.43, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 38.1
Fwd PE 29.95
MNST Price Earnings VS Forward Price EarningsMNST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

62.50% of the companies in the same industry are cheaper than MNST, based on the Enterprise Value to EBITDA ratio.
MNST's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 34.32
EV/EBITDA 27.53
MNST Per share dataMNST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MNST does not grow enough to justify the current Price/Earnings ratio.
MNST has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as MNST's earnings are expected to grow with 12.98% in the coming years.
PEG (NY)2.1
PEG (5Y)N/A
EPS Next 2Y14.53%
EPS Next 3Y12.98%

More info and screens

0

5. Dividend

5.1 Amount

MNST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONSTER BEVERAGE CORP

NASDAQ:MNST (5/21/2025, 11:03:09 AM)

63.24

+0.25 (+0.4%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners68.51%
Inst Owner Change-0.12%
Ins Owners0.41%
Ins Owner Change6.47%
Market Cap61.67B
Analysts74.38
Price Target60.11 (-4.95%)
Short Float %2.49%
Short Ratio2.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.47%
Min EPS beat(2)-6.99%
Max EPS beat(2)0.06%
EPS beat(4)1
Avg EPS beat(4)-6.66%
Min EPS beat(4)-11.44%
Max EPS beat(4)0.06%
EPS beat(8)2
Avg EPS beat(8)-4.49%
EPS beat(12)3
Avg EPS beat(12)-5.41%
EPS beat(16)4
Avg EPS beat(16)-4.88%
Revenue beat(2)0
Avg Revenue beat(2)-4.61%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)-0.98%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)-0.98%
Revenue beat(8)0
Avg Revenue beat(8)-3.85%
Revenue beat(12)1
Avg Revenue beat(12)-3.56%
Revenue beat(16)4
Avg Revenue beat(16)-1.96%
PT rev (1m)4.16%
PT rev (3m)6.56%
EPS NQ rev (1m)3.47%
EPS NQ rev (3m)2.11%
EPS NY rev (1m)1.84%
EPS NY rev (3m)0.75%
Revenue NQ rev (1m)1.97%
Revenue NQ rev (3m)1.87%
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)-0.73%
Valuation
Industry RankSector Rank
PE 38.1
Fwd PE 29.95
P/S 8.28
P/FCF 34.32
P/OCF 30.47
P/B 9.46
P/tB 16.35
EV/EBITDA 27.53
EPS(TTM)1.66
EY2.62%
EPS(NY)2.11
Fwd EY3.34%
FCF(TTM)1.84
FCFY2.91%
OCF(TTM)2.08
OCFY3.28%
SpS7.64
BVpS6.69
TBVpS3.87
PEG (NY)2.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.35%
ROE 23.16%
ROCE 29.78%
ROIC 23.04%
ROICexc 31.64%
ROICexgc 68.61%
OM 28%
PM (TTM) 20.27%
GM 54.64%
FCFM 24.13%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
ROICexc(3y)29.02%
ROICexc(5y)32.32%
ROICexgc(3y)64.44%
ROICexgc(5y)84.58%
ROCE(3y)25.4%
ROCE(5y)26.54%
ROICexcg growth 3Y-12.83%
ROICexcg growth 5Y-13.62%
ROICexc growth 3Y-5.49%
ROICexc growth 5Y-2.02%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.12
Debt/EBITDA 0.09
Cap/Depr 267.77%
Cap/Sales 3.05%
Interest Coverage 71.04
Cash Conversion 93.27%
Profit Quality 119%
Current Ratio 3.37
Quick Ratio 2.78
Altman-Z 25.09
F-Score7
WACC9.1%
ROIC/WACC2.53
Cap/Depr(3y)319.34%
Cap/Depr(5y)225.06%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.29%
Profit Quality(3y)86.9%
Profit Quality(5y)86.95%
High Growth Momentum
Growth
EPS 1Y (TTM)3.75%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%11.9%
EPS Next Y18.16%
EPS Next 2Y14.53%
EPS Next 3Y12.98%
EPS Next 5Y13.22%
Revenue 1Y (TTM)1.47%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%-2.35%
Revenue Next Year6.3%
Revenue Next 2Y7.13%
Revenue Next 3Y7.11%
Revenue Next 5Y8.08%
EBIT growth 1Y3.72%
EBIT growth 3Y4.5%
EBIT growth 5Y7.79%
EBIT Next Year13.77%
EBIT Next 3Y10.87%
EBIT Next 5Y10.65%
FCF growth 1Y62.57%
FCF growth 3Y14.4%
FCF growth 5Y10.46%
OCF growth 1Y54.2%
OCF growth 3Y18.61%
OCF growth 5Y11.61%